RSV

RSV Vaccination to Reduce Recurrent AECOPD

A Phase 2 Study to Investigate the Efficacy and Safety of Zelicapavir in Participants Aged ≥28 Days to ≤36 Months of Age Infected With Respiratory Syncytial Virus

Clinical Evaluation of the VitaSIRO Solo™ Respiratory Assay

Concurrent Versus Sequential Administration of Tdap and RSV Vaccines in Pregnancy

Study to Evaluate the Safety of a Lyophilized RSV mRNA Vaccine

Clinical Outcomes and Pharmacotherapy Effectiveness in the VA Health Care System (COPE-VA)

RSV Burden in Hong Kong

Covid Flu A/B and RSV 4 in 1 Diagnostic Test

Vaccine Effectiveness of a Bivalent RSV Prefusion F Protein-Based Vaccine for Preventing RSV Hospitalizations in Adults

Preparedness Through Respiratory Virus Epidemiology and Community Engagement

Clinical Validation of the Aptitude Medical Systems Metrix Respiratory Panel Test in At-Home/Non-Laboratory Settings

SURVEILLANCE, ASSESSMENT AND DETECTION OF INFLUENZA ASSOCIATED RESPIRATORY INFECTIONS IN HIV POSITIVE AND NEGATIVE INDIVIDUALS IN LUSAKA, ZAMBIA

A Multi-Site Clinical Evaluation of the LIAISON NES FLU A/B, RSV & COVID-19 Assay in Symptomatic Patients

Effectiveness And Impact Of Nirsevimab In Chile (NIRSE-CL)

A Safety, Reactogenicity, and Immunogenicity Study of mRNA-1045 (Influenza and Respiratory Syncytial Virus [RSV]) or mRNA-1230 (Influenza, RSV, and Severe Acute Respiratory Syndrome Coronavirus 2 [SARS-CoV-2]) Vaccine in Adults 50 to 75 Years Old

Clinical Lot Consistency for RSVpreF in a Population of Healthy Adults 18 to ≤49 Years of Age

Adherence to Palivizumab Prophylaxis

The Impact of a Short Intervention During RSV Prophylaxis on Influenza Vaccination Rate.